LEQEMBI DIN 02562383
Health Canada record
| Active ingredient(s) | LECANEMAB 100 MG |
|---|---|
| Dosage form | Solution |
| Route | Intravenous |
| Schedule | SCHEDULE D; PRESCRIPTION |
| Class | Human |
| ATC | N06DX04 LECANEMAB |
| Original market date | 16-Dec-2025 |
| Current status date | 16-Dec-2025 |
| Source | Health Canada DPD |
Establishment licence of the holder
Eisai Limited — licence 101843, currently licensed, last inspection rating C (2023-03-29).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 36245 | 2025-10-24 | New Drug Submission (NDS) |